Toward precision approaches for the prevention and treatment of obesity

JAMA - Journal of the American Medical Association

Volumn 319, Issue 3, 2018, Pages 223-224

  Yanovski, Susan Z ^a   Yanovski, Jack A ^b  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEPTIN;

BODY MASS; EPIGENETICS; FOOD PREFERENCE; GENETIC ASSOCIATION; GENOTYPE ENVIRONMENT INTERACTION; HIGH RISK POPULATION; HUMAN; LIFESTYLE; OBESITY; OBESITY MANAGEMENT; PATIENT-REPORTED OUTCOME; PERSONALIZED MEDICINE; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; RISK REDUCTION; SHORT SURVEY; TREATMENT PLANNING; TREATMENT RESPONSE; WEIGHT LOSS PROGRAM; GENETICS;

HUMANS; OBESITY; PRECISION MEDICINE;

EID: 85040982219     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2017.20051     Document Type: Short Survey

References (10)

1. Hales CM, Carroll MD, Fryar CD, Ogden CL. Prevalence of Obesity Among Adults and Youth: United States, 2015-2016. Vol 288. Hyattsville, MD: US Dept of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics; 2017:1-8.
2. Schulz LO, Bennett PH, Ravussin E, et al. Effects of traditional and western environments on prevalence of type 2 diabetes in Pima Indians in Mexico and the US. Diabetes Care. 2006;29(8): 1866-1871.
3. Farooqi IS, Keogh JM, Yeo GS, Lank EJ, Cheetham T, O'Rahilly S. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med. 2003;348(12):1085-1095.
4. Frayling TM, Timpson NJ, Weedon MN, et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science. 2007;316(5826):889-894.
5. Rask-Andersen M, Karlsson T, Ek WE, Johansson A. Gene-environment interaction study for BMI reveals interactions between genetic factors and physical activity, alcohol consumption and socioeconomic status. PLoS Genet. 2017;13(9): E1006977.
6. Stubbs J, Whybrow S, Teixeira P, et al. Problems in identifying predictors and correlates of weight loss and maintenance: Implications for weight control therapies based on behaviour change. Obes Rev. 2011;12(9):688-708.
7. Yanovski SZ, Yanovski JA. Long-term drug treatment for obesity: A systematic and clinical review. JAMA. 2014;311(1):74-86.
8. Nicoletti CF, Cortes-Oliveira C, Pinhel MAS, Nonino CB. Bariatric surgery and precision nutrition. Nutrients. 2017;9(9):E974.
9. Unick JL, Neiberg RH, Hogan PE, et al; Look AHEAD Research Group. Weight change in the first 2 months of a lifestyle intervention predicts weight changes 8 years later. Obesity (Silver Spring). 2015; 23(7):1353-1356.
10. Kuhnen P, Clement K, Wiegand S, et al. Proopiomelanocortin deficiency treated with a melanocortin-4 receptor agonist. N Engl J Med. 2016;375(3):240-246.